Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics.

Cavallaro, Palmira Alessia; De Santo, Marzia; Belsito, Emilia Lucia; Longobucco, Camilla; Curcio, Manuela; Morelli, Catia; Pasqua, Luigi; Leggio, Antonella

Cavallaro, Palmira Alessia; De Santo, Marzia; Belsito, Emilia Lucia; Longobucco, Camilla; Curcio, Manuela; Morelli, Catia; Pasqua, Luigi; Leggio, Antonella.

Afiliação

Cavallaro PA; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, 87036 Rende, Italy.
De Santo M; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, 87036 Rende, Italy.
Belsito EL; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, 87036 Rende, Italy.
Longobucco C; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, 87036 Rende, Italy.
Curcio M; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, 87036 Rende, Italy.
Morelli C; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, 87036 Rende, Italy.
Pasqua L; Department of Environmental Engineering, University of Calabria, Via P. Bucci, 87036 Rende, Italy.
Leggio A; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, 87036 Rende, Italy.

Nanomaterials (Basel) ; 13(17)2023 Sep 01.

Article em En | MEDLINE | ID: mdl-37686984

Palavras-chave

HER2-positive breast cancer; drug delivery; monoclonal antibodies; nanoparticles; targeting peptides; tumor imaging

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Idioma: En Revista: Nanomaterials (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google